Sorafenib-dacarbazine combination shows activity in metastatic melanoma. Comment

Jeffrey A. Sosman*

*Corresponding author for this work

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)109-110
Number of pages2
JournalOncology Report
Issue numberFALL
StatePublished - Sep 2005

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this